(1)
2020 Consensus Guideline for Optimal Approach to the Diagnosis and Treatment of HER2-Positive Breast Cancer in Bosnia and Herzegovina.
Biomol Biomed
2021
,
21
(2), 120-135.
https://doi.org/10.17305/bjbms.2020.4846
.